Qingxia Zhao

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · BMJ · 2020 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · medRxiv · 2020 · 198 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +12

Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention

Li Sun, Youmei Peng, Wenquan Yu et al. · Journal of Medicinal Chemistry · 2020 · 73 citations

Medicine, Pharmacokinetics, Pharmacology +17

Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy

Zheng Zhang, Junliang Fu, Qingxia Zhao et al. · The Journal of Immunology · 2006 · 61 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation

Yan-Heng Zhou, Li Sun, Jun Chen et al. · mBio · 2019 · 52 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16